Products & Services | Company | Contact

About GlycoBioChem

GlycoBioChem is a University of Dundee biopharmaceutical spin out limited company focused on the discovery and development of novel small-molecules for the purposes of research and treatment of human diseases.

The company currently markets PRODRG, software designed to generate three-dimensional models of chemicals for use in applications such as rational drug design. In addition GlycoBioChem will also market a range of unique innovative molecular and chemical tools developed specifically for research into carbohydrate processing enzymes, implicated in several diseases including cancer, Alzheimer’s, and diabetes.

GlycoBioChem is also developing a drug discovery program, currently focussed on a novel target implicated in the development of Alzheimer’s disease in collaboration with the Group of Daan van Aalten at the University of Dundee. To this end we are interested in partnering with other pharmaceutical companies to further develop our inhibitor portfolio.


Dr Francesco Rao

Managing Director

Francesco Rao was awarded his BSc (Hons) in Biochemistry from the University of Edinburgh in 2001. This was followed by a Masters and Industrial CASE PhD (with Syngenta) in Structural Biology at the University of Dundee. In 2007, Francesco received an EMBO and Michael Smith fellowships to carry out postdoctoral studies in the lab of Professor Stephen Withers and Professor Natalie Strynadka at the University of British Columbia, Vancouver. Francesco returned to Europe upon receiving a FEBS fellowship and a Marie Curie International Re-Intergration grant. Francesco has extensive experience in the technologies, services and products offered by GlycoBioChem.

Prof Daan van Aalten

Scientific Director

Daan van Aalten gained a BSc in Chemistry from the University of Nijmegen in the Netherlands, followed by a PhD in Biochemistry/Biocomputing at the University of Leeds. After postdoctoral work in protein crystallography at Cold Spring Harbor Laboratory, on an EMBO Long Term Fellowship, and the University of Oulu, Finland, he established his own group at the University of Dundee with the help of a Wellcome Trust Career Development Fellowship, with a research focus in the area of molecular & cellular glycobiology. In 2002 he won an EMBO Young Investigator Award, in 2004 a Wellcome Trust Senior Research Fellowship and in 2006 the Lister Prize. Daan has a personal chair in biological chemistry as of 2006, and is author on over 120 scientific papers. His current interests are the molecular basis of biogenesis of the fungal cell wall, and the role of O-GlcNAc in modulating phospho-dependent signal transduction in higher eukaryotes.

Dr Alexander Schüttelkopf



Dr Vladimir Borodkin



Employment Opportunities

There are currently no open positions at GlycoBioChem.